在性结肠炎中,牙问题和口腔微生物组的改变
Robert Kucharski1,2, Bartosz Kamil Sobocki3, Ewa Stachowska4
1Department of Medical Laboratory Diagnostics - Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, Gdańsk, Poland.
Frontiers in immunology
|February 20, 2025
概括
性结肠炎与口腔微生物组的变化有关,包括减少多样性和增加牙周病原体. 分析口腔健康可能有助于为性结肠炎患者提供个性化医疗.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC) 的发病包括微生物失调,导致肠道微生物组失衡.
- 口腔微生物组的变化越来越被认为是UC的一个因素.
- UC患者经常出现各种牙科问题,包括牙周炎和更高的DMFT指数.
研究的目的:
- 探索性结肠炎和口腔微生物组变化之间的关联.
- 突出口腔微生物组分析作为UC生物标志物的潜力.
- 强调牙表现在UC综合管理中的重要性.
主要方法:
- 关于性结肠炎和口腔微生物组的当前文献的综述.
- 对将UC与特定的口腔病原体和牙科疾病联系起来的研究分析.
- 检查口腔微生物组在UC病变发生中的作用和作为生物标记物的潜力.
主要成果:
- UC与口腔微生物组合的显著变化有关,包括细菌多样性的减少.
- 牙周病原体如 * Porphyromonas gingivalis * 和 * Fusobacterium nucleatum * 都涉及到这一问题.
- 患有UC的患者表现出更高的牙损伤,牙周炎和其他口腔健康问题.
结论:
- 口腔微生物组是性结肠炎的潜在生物标志物,有助于个性化医疗方法.
- 了解UC,口腔微生物组和免疫学之间的相互作用对于综合牙科治疗至关重要.
- 牙表现和口腔健康状况应在性结肠炎患者的整体护理中考虑.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
122
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
122
Chronic Bowel Disorders: Introduction
380
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
380
Inflammatory Bowel Disease II: Crohn's Disease
166
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
166
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
344
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
344
Peptic Ulcer Disease I: Introduction
119
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
119
Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118


